60 results
Page 3 of 3
6-K
EX-99.2
6e640i
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.9
a1adlg1 uil
20 Sep 19
Current report (foreign)
4:07pm
6-K
EX-99.3
yvm5u
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.4
swds9kqrc0nkj7iyc0k
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99.2
fbxxj8m 8wh0vj
29 Aug 19
Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration
4:44pm
6-K
EX-99
40x5buayzw9c7r
25 Jul 19
Strong clinical progress in H1, and transformative collaboration with Gilead announced
4:24pm
6-K
EX-99.2
o0sqxxijz3b57003h
26 Apr 19
Galapagos reports on historic first quarter 2019
4:06pm
6-K
EX-99.2
3t963api42
26 Oct 18
Hallmark third quarter 2018 and Annual R&D Update at Galapagos
4:19pm
424B5
9nb7wnskhc0i6cq236j
13 Sep 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
bb5l83
2 Aug 18
Current report (foreign)
4:03pm
6-K
EX-99.2
r4ci5yx2fh7ddrkh 9s4
27 Apr 18
Galapagos reports first quarter 2018 results
12:00am
6-K
EX-1.1
u5suxrt x3
18 Apr 17
Galapagos announces launch of proposed public offering
12:00am
424B5
fo9tue0 8u
18 Apr 17
Prospectus supplement for primary offering
12:00am
424B5
cttex96 49yxye4
17 Apr 17
Prospectus supplement for primary offering
12:00am
20-F
bx1h ko7aki2un45vq
25 Mar 16
Annual report (foreign)
12:00am
DRS
vxys8 ek44
6 Feb 15
Draft registration statement
12:00am
DRS
EX-10
t9tt63
6 Feb 15
Draft registration statement
12:00am